It’s clear that patients & the entire healthcare system need a robust pharma & industrial policy to prevent shortages. We have drafted the commendations in our #MedsSecurityAct European Parliament - European Commission medicinesforeurope.com/wp-content/upl…

On November 7 @MedicinesforEU’s #VAM23 Conference is back in Brussels! Visit our website to get all the latest updates on the event medicinesforeurope.com/events/vam23/ and register now!

#BiosimilarMedicines competition forms an important pillar of European healthcare systems equilibrium and a necessary enabler to patient access to biologic medicines. Read our 2023 market review medicinesforeurope.com/wp-content/upl…

Join #VAM23 to have a peek to what the future of #ValueAddedMeds may look like thanks to the information collected from real world experience. 🗓️ 7/11 - BXL, find more information on the programme medicinesforeurope.com/events2023/VAM…

SAVE THE DATES: 6 – 10 November📝 One month from now join us for the #VAMweek! Don’t miss out on the opportunity to share your knowledge on #ValueAddedMeds shedding a light on their importance for patients! medicinesforeurope.com/events/vam23/

Thanks to the collection of real world data, it’s easier for the off-patent sector to find novel uses of known medicines. How it positively affects patients will be discussed at #VAM23, Nov 7- BXL register now! medicinesforeurope.com/events2023/vam…

Last year, during our annual conference we presented our study on how new pricing policies for #GenericMedicines can ensure long-term healthy competitiveness in Europe medicinesforeurope.com/2022/06/30/new…

Newly published, the article below reiterates the importance of the identification of new potential pricing models medicinesforeurope.com/news/new-prici… Listen to our podcast on the consequences of #inflation with Adrian van den Hoven, Victor Mendonça & Clément François medicinesforeurope.com/podcast/

Two weeks from now we will discuss all the latest advancements on #ValueAddedMeds in Brussels Don’t miss all you need to know on these innovative medicines 🟣 Check the programme medicinesforeurope.com/events2023/VAM… 🟣 Register medicinesforeurope.com/events2023/vam…

Thanks to #ValueAddedMeds almost 7 million seizures in children have been treated over the past 5 years! Would you like to know more about all the advantages of #MedsRepurposing? Follow #VAMweek! medicinesforeurope.com/docs/white-pap…

💡 Supporting patients' adherence to treatment 💡 Lowering the burden on healthcare providers are just some of the benefits that #MedsRepurposing has to offer and we will explore more during #VAMweek, follow the hashtag! medicinesforeurope.com/value-added-me…

Thank you for joining this year’s #GlobalBiosimilarsWeek ! Tune in to @IGBA & our channels if you want follow all updates on #BIosimilarMedicines until #GBW24 ! #GBW23 🧪globalbiosimilarsweek.org/2022/

📢WE ARE HIRING📢 Check our website and discover the current vacancies🔎 lnkd.in/gMh9jpsC

#CoEUP is back!🎙️ Hosted by Adrian van den Hoven, our 5th episode focuses on the risks that #shortages pose to Europeans and the actions that can be taken from a policy perspective to prevent supply chain disruption💊 Available on 10 podcasting platforms medicinesforeurope.com/podcast/

« What the law hath given, the courts are taking away! » claim disappointed medicine copiers Medicines for Europe Adrian van den Hoven EFPIA EUCOPE

The new EU #Pharma and #IP legislation will shape your future generic and biosimilar medicine development and launch strategies. Find more information in our paper addressing what can be done for #access through the #EUPharmaStrategy review📝 shorturl.at/ehqAY

📢join us in Dublin, at #MedsforEU24📢 medicinesforeurope.com/events/annual2… & #LAC24 medicinesforeurope.com/events/lac2024/

Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told World Health Organization (WHO)'s Fair Pricing Forum. World Health Organization (WHO) Adrian van den Hoven Roche Kerry Cullinan healthpolicy-watch.news/evergreening-m…

All patients deserve better and more secure #access to medicines 🫶 Read our latest #PressRelease to discover more on our contribution at the international conference Expert Forum together with other key stakeholders medicinesforeurope.com/wp-content/upl… #AccessForAll

🗓️ Mark your calendars for 26 Sept! Join the #EHFG2024 panel on access to critical medicines & supply chain solutions – key topics on the European health agenda. Be part of the conversation, organised by Viatris EU Policy & @MedicinesforEU 👉 bit.ly/4bW540n